Skip to main content

Table 1 Characteristics of both cohorts of patients, receiving (FBNc group) or not (comparator group) FBNc

From: Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group

Variables

FBNc N = 71

Comparator N = 72

P value

Age (years)

57 [44, 66]

63 [53, 72]

0.02

SOFA

7 [4, 10]

5 [3, 8]

0.03

Gender (males)

46 (65)

55 (76)

NS

Haemorrhage occurring outside the OR or ICU

25 (35.2)

24 (33.3)

NS

Diagnoses

   

Cardiac Surgery

37 (51.4)

35 (49.3)

NS

Liver Transplantation

11 (15.3)

11 (15.5)

 

Gastrointestinal Bleeding

16 (22.2)

15 (21.1)

 

Other

8 (11.1)

10 (14.1)

 

Variables at beginning of the bleeding

   

pH

7.30 [7.29, 7.32]

7.31 [7.26, 7.3]

NS

Base excess (mEq/L)

-4.3 [-7.3, -3.0]

-4.0 [-6.2, 0.3]

0.04

Creatinine (mg/dl)

0.9 [0.7, 1.3]

0.9 [0.7, 1.6]

NS

Leukocytes (x 109/L)

7.4 [4.7, 12.9]

10.3 [8.1,14.6]

0.04

Platelets (x 109/L)

93 [49, 150]

100 [63, 144]

NS

Haemoglobin (g/L)

85.0 [71.5, 103.0]

70.0 [64.0, 75.0]

0.001

Prothrombin time (s)

19.2 [14.1, 31.6]

16.7 [14.7, 20.3]

NS

Thromboplastin time (s)

46.1 [34.1, 97.3]

43.5 [34.0, 55.5]

NS

Fibrinogen (g/L)

1.3 [0.9, 2.2]

2.0 [1.4, 3.1]

0.001

INR

1.7 [1.2, 2.8]

1.4 [1.2, 1.7]

0.01

Outcome variables

   

In-hospital mortality

29 (40.8)

20 (27.8)

NS

Length of hospital stay (days)*

14 [7, 30]

23 [17, 33]

0.01

PRBC (units)

9 [5, 16]

6 [4,10]

0.001

FFP (units)

2 [0, 6]

3 [0, 6]

NS

Platelet (pools)

2 [1, 3]

1 [0, 2]

0.001

Total transfusion (units)

15 [8, 25]

10 [6, 18]

0.02

  1. FBNc: Fibrinogen concentrate; SOFA: Sepsis organ failure assessment; OR: Operating room; ICU: Intensive care unit; INR: International normalized ratio; PRBC: Packed red blood cell; FFP: Fresh frozen plasma; Quantitative variables are expressed as a median [interquartile range]. Qualitative variables are expressed as a number (percentage).